You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
人福醫藥(600079.SH):異氟烷注射液申報生產獲受理
格隆匯 03-09 16:42

格隆匯3月9日丨人福醫藥(600079.SH)公佈,公司控股子公司宜昌人福近日收到國家藥品監督管理局核准簽發的異氟烷注射液申報生產的《受理通知書》,經審查,決定予以受理。

異氟烷注射液適用於全身麻醉的誘導。目前國內已上市異氟烷製劑為吸入劑,根據米內網數據顯示,2020年異氟烷吸入劑在我國城市、縣級及鄉鎮三大終端公立醫院的銷售額約為人民幣3600萬元,主要生產廠商包括河北一品製藥股份有限公司、魯南貝特製藥有限公司等。與吸入劑相比,異氟烷注射液麻醉誘導迅速、甦醒快、循環穩定,特別適用於門診短小手術、診斷性檢查、快速誘導插管等情形。截至目前,宜昌人福該項目累計投入約為5500萬元人民幣。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account